Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

23.80p
   
  • Change Today:
      1.80p
  • 52 Week High: 45.85p
  • 52 Week Low: 17.70p
  • Currency: UK Pounds
  • Shares Issued: 741.51m
  • Volume: 2,445,829
  • Market Cap: £176.48m
  • Beta: 0.02

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-24 Q1 17.72 (7.07) (0.98)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-20 105.57 (22.57) (3.80)p n/a n/a n/a n/a 0.0%
30-Sep-21 125.06 (9.18) (1.93)p n/a n/a n/a n/a 0.0%
30-Sep-22 157.71 (21.38) (4.34)p n/a n/a n/a n/a 0.0%
30-Sep-23 103.96 (24.70) (3.21)p n/a n/a n/a n/a 0.0%
30-Sep-24 90.36 (45.92) (5.99)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-25 82.60 1.40 13.71p 1.7 n/a n/a n/a 0.0%
30-Sep-26 86.25 10.85 1.20p 19.8 n/a -91% n/a 0.0%
30-Sep-27 94.45 12.20 1.60p 14.9 0.4 +33% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price 23.80p
Change Today 1.80p
% Change 8.18 %
52 Week High 45.85p
52 Week Low 17.70p
Volume 2,445,829
Shares Issued 741.51m
Market Cap £176.48m
Beta 0.02

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.89% above the market average65.89% above the market average65.89% above the market average65.89% above the market average65.89% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average
Price Trend
75.17% below the market average75.17% below the market average75.17% below the market average75.17% below the market average75.17% below the market average
40.43% below the sector average40.43% below the sector average40.43% below the sector average40.43% below the sector average40.43% below the sector average
Income Not Available
Growth
57.38% below the market average57.38% below the market average57.38% below the market average57.38% below the market average57.38% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
13:13 4,131 @ 23.80p
13:13 55,387 @ 23.80p
13:13 132,113 @ 23.80p
12:36 33,333 @ 23.80p
11:32 30,000 @ 23.75p

BMK Key Personnel

CFO Septima Maguire
CEO Trond Williksen
Chair Tripp Lane

Top of Page